BridgeMD
New treatment option for Development, Child
Official title Reference Values for the Muscle Power Sprint Test
ClinicalTrials.gov ID: NCT06448520
What this study is testing
- What it's testing
- The goal of this prospective, cross-sectional study is to develop updated reference values for the Muscle Power Sprint Test (MPST) in children aged 5-12 years. The main question it aims to answer is: What are reference ('normal') values for the MPST in children aged 5-12 years?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 5 to 12. Healthy volunteers may be eligible.
You may be able to join if
- Age 5-12 years
- Attending primary education at one of the participating schools or attending participating after-school childcare centers.
You likely can't join if
- Contra-indication for maximal exercise due to cardiac or respiratory morbidities
- Injuries limiting maximal exercise capacity
- Known with motor function impairment which may hamper maximal exercise (e.g. neurologic comorbidities)
The study team makes the final eligibility decision.
Where it's taking place
- Rotterdam, South Holland, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 5 years to 12 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rotterdam, South Holland, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.